Literature DB >> 7665397

Peroxide-cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics.

S Chemtob1, P Hardy, D Abran, D Y Li, K Peri, O Cuzzani, D R Varma.   

Abstract

To test the role of reactive oxygen species and cyclooxygenase products in the retinal hemodynamic changes induced by asphyxia, we measured retinal (RBF) and choroidal blood flows (ChBF), malondialdehyde (MDA), prostaglandin E2 (PGE2), 6-ketoprostaglandin F1 alpha (6-keto-PGF1 alpha), and thromboxane B2 (TxB2) in 1- to 3-day-old pigs treated with saline, the free radical scavengers U-74389F or high-dose allopurinol, the cyclooxygenase inhibitors ibuprofen or indomethacin, or the thromboxane synthase blocker CGS-13080 before and 5 and 60 min after a 5-min period of asphyxia. In saline-treated animals, RBF and ChBF increased 5 min after asphyxia and decreased at 60 min. The increases in RBF and ChBF at 5 min postasphyxia were slightly attenuated by cyclooxygenase blockers and free radical scavengers but not by thromboxane synthase inhibition, whereas all drugs prevented the decreases at 60 min. MDA, TxB2, PGE2, and 6-keto-PGF1 alpha increased 5 min after asphyxia; at 60 min, PGE2 and 6-keto-PGF1 alpha returned to nearly preasphyxial levels, but MDA and TxB2 continued to increase. Cyclooxygenase inhibition prevented the asphyxia-induced rise in MDA, and the free radical scavengers prevented that of prostanoids. In isolated eyecup preparations, H2O2 and cumene hydroperoxide constricted retinal arteries; this effect was blocked by cyclooxygenase and thromboxane synthase inhibitors. The data suggest that during oxidative stresses reactive oxygen species are generated from the cyclooxygenase pathway and, in turn, also activate the synthesis of thromboxane; the latter mediates the oxidative stress-induced ocular vasoconstriction that might trigger the neovascularization of retinopathy of prematurity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7665397     DOI: 10.1152/jappl.1995.78.6.2039

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

1.  Oxygen free radicals and retinopathy of prematurity.

Authors:  N A Rao; G S Wu
Journal:  Br J Ophthalmol       Date:  1996-05       Impact factor: 4.638

Review 2.  Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life.

Authors:  Przemyslaw Sapieha; Jean-Sebastien Joyal; José Carlos Rivera; Elsa Kermorvant-Duchemin; Florian Sennlaub; Pierre Hardy; Pierre Lachapelle; Sylvain Chemtob
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 3.  Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Clin Perinatol       Date:  2014-09-23       Impact factor: 3.430

Review 4.  Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.

Authors:  Batoule H Majed; Raouf A Khalil
Journal:  Pharmacol Rev       Date:  2012-06-07       Impact factor: 25.468

5.  Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats.

Authors:  P Sicard; N Acar; S Grégoire; B Lauzier; A M Bron; C Creuzot-Garcher; L Bretillon; C Vergely; L Rochette
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

Review 6.  The effect of oxygen and light on the structure and function of the neonatal rat retina.

Authors:  A L Dorfman; S Joly; P Hardy; S Chemtob; P Lachapelle
Journal:  Doc Ophthalmol       Date:  2008-05-16       Impact factor: 2.379

7.  Triamcinolone acetonide prevents enhancement of hypoxia-induced neuronal and inducible nitric oxide synthases in the retinas of rats with oxygen-induced retinopathy.

Authors:  Seong Jae Kim; In Young Chung; Wan Sung Choi; Young Hee Kim; Ji Myong Yoo
Journal:  Korean J Ophthalmol       Date:  2012-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.